+Vote!
Business Wire (Free subscription) | 10/03/2008
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting
+Vote!
The Industry Standard (Free subscription) | 09/25/2008
Shares of some top medical companies are up at 10 a.m.: Abbott Labs rose $.50 or .8 percent, to $59.35. Allergan rose $.89 or 1.6 percent, to $56.86. Bard rose $1.50 or 1.6 percent, to $97.25. Boston Scientific rose $.59 or 4.7 percent, to $13.20. Hospira rose $.68 or 1.8 percent, to $39.31. Johnson & Johnson rose $1.19 or 1.7 percent, to $69.38. Medtronic rose $.68 or 1.3 percent, to $52.82. St Jude...
2Vote!
Business Wire (Free subscription) | 09/24/2008
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting
+Vote!
The Industry Standard (Free subscription) | 09/23/2008
Shares of some top medical companies were mixed at the close of trading: Abbott Labs fell $1.57 or 2.7 percent, to $57.14. Allergan fell $.72 or 1.2 percent, to $57.96. Bard rose $1.03 or 1.1 percent, to $96.01. Boston Scientific fell $1.18 or 8.6 percent, to $12.47. Hospira fell $1.18 or 3.1 percent, to $37.32. Johnson & Johnson fell $1.58 or 2.3 percent, to $68.41. Medtronic fell $.69 or 1.3 percent,...
+Vote!
Medical News Today (Free subscription) | 09/22/2008
Since Allergan received FDA approval in 2002 to market Botox as a facial rejuvenation procedure, the product has become the second most-recognized pharmaceutical brand in the U.S. Allergan has a formidable presence in this area since its formula is secret and the highly purified toxin is difficult to replicate.
+Vote!
Market Wire (Free subscription) | 09/17/2008
NEW YORK, NY (MARKET WIRE) Since Allergan received FDA approval in 2002 to market Botox as a facial rejuvenation procedure, the product has become the second most-recognized pharmaceutical brand in the U.S. Allergan has a formidable presence in this area since its formula is secret and the highly purified toxin is difficult to replicate. Still, according to Kalorama Information's new report "Facial...
+Vote!
The Onion (Free subscription) | 09/15/2008
Pharmaceutical company Allergan says its paralysis-inducing wrinkle preventer Botox works as a treatment for chronic migraines. What do you ...
+Vote!
Science - The Post Chronicle (Free subscription) | 09/13/2008
Allergan Inc. said it hopes to file an application with the U.S. Food and Drug Administration for the use of Botox in patients with chronic migraines by the......
2Vote!
Red Orbit (Free subscription) | 09/13/2008
A U.S. drug maker said two Phase III clinical trials show Botox injections can help prevent chronic migraines. Allergan Inc. said it hopes to file an application with the U.S.
+Vote!
Fool.com (Free subscription) | 09/12/2008
Allergan's muscle relaxant Botox performs well in two studies.
+Vote!
Business Week (Free subscription) | 09/12/2008
S&P Picks and Pans: Lehman, Merrill Lynch, WaMu, CSX, AllerganAnalysts' opinions on stocks in the news Thursday From S&P MAINTAINS HOLD RECOMMENDATION ON SHARES OF LEHMAN BROTHERS (; 7.25): Update: An unconfirmed story from the Associated Press reports that LEH has reached out to other large financial institutions about a potential acquisition of, or investment in, the company. We think this assertion...
+Vote!
Red Orbit (Free subscription) | 09/11/2008
Allergan Inc reported Thursday that its product Botox is helpful for patients suffering from chronic migraines. Botox, or botulinum toxin type A, is commonly used as a cosmetic treatment to smooth out unwanted wrinkles.An estimated 1.2 million to 3.6 million people in the U.S.
